Neurobiological mechanisms by which nicotine mediates different types of anxiety

European Journal of Pharmacology

Volumn 393, Issue 1-3, 2000, Pages 231-236

  File, Sandra E ^a   Cheeta, Survjit ^a   Kenny, Paul J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

5 HT(1A) receptor; Anxiety; Hippocampus, dorsal; lateral; Nicotine; Phobia; Septum

Indexed keywords

MECAMYLAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NICOTINE; SEROTONIN 1A ANTAGONIST;

ANIMAL MODEL; ANXIETY; BRAIN REGION; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; HIPPOCAMPUS; MAZE TEST; NONHUMAN; PHOBIA; PRIORITY JOURNAL; RAT; SEPTUM NUCLEUS; SEROTONIN RELEASE; SOCIAL INTERACTION;

ANIMALS; ANXIETY; HIPPOCAMPUS; INTERPERSONAL RELATIONS; MAZE LEARNING; MECAMYLAMINE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RATS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEPTAL NUCLEI; SEROTONIN ANTAGONISTS;

EID: 0034732093     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00889-4     Document Type: Conference Paper

References (47)

1. 1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur. J. Pharmacol. 264:1994;259-264.
2. Brioni J.D., O'Neill A.B., Kim D.J., Buckley M.J., Decker M.W., Americ S.P. Anxiolytic-like effects of the novel cholinergic channel activator ABT-418. J. Pharmacol. Exp. Ther. 271:1994;353-361.
3. 1A receptors in mediating the anxiogenic effects of nicotine following lateral septal administration. Eur. J. Neuro-Psychopharmacol. 9:1999;S303.
4. Cheeta S., Kenny P., File S.E. Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2000;. (in press).
5. Fernandes C., File S.E. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol. Biochem. Behav. 54:1996;31-40.
6. File S.E. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J. Neurosci. Methods. 2:1980;219-238.
7. File S.E. One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology. 100:1990;281-282.
8. File S.E. Behavioural detection of anxiolytic action. Elliot J.M., Heal D.J., Marsden C.A. Experimental Approaches to Anxiety and Depression. 1992;25-44 Wiley, London.
9. File S.E. The interplay of learning and anxiety in the elevated plus-maze. Behav. Brain Res. 58:1993;199-202.
10. File S.E. Animal measures of anxiety. Crawley J.N., Gerfen C.R., McKay R., Sibley D.R., Skolnick P. Current Protocols in Neuroscience. 1997;8.3.1-8.3.15 Wiley.
11. File S.E., Cheeta S., Kenny P.J., Ouagazzal A.-M., Gonzalez L.E. Roles of the dorsal raphe nucleus, lateral septum and the dorsal hippocampus in nicotine's effects on anxiety. Soc. Neurosci., Abstr. 25:1999;1981.
12. 1A-receptor ligands in dorsal raphé and ventral hippocampus. Pharmacol. Biochem. Behav. 54:1996;123-128.
13. 1A receptor modulation of anxiety in two ethological animal tests. J. Neurosci. 16:1996;10-4815.
14. 1 receptors. Behav. Neurosci. 112:1998;352-359.
15. File S.E., Gonzalez L.E., Gallant R. Role of the basolateral nucleus of the amygdala in the formation of a phobia. Neuropsychopharmacology. 19:1998;397-405.
16. File S.E., Gonzalez L.E., Gallant R. Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety. Neuropsychopharmacology. 21:1999;312-320.
17. File S.E., Kenny P.J., Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol. Biochem. Behav. 2000;. (in press).
18. File S.E., Kenny P.J., Ouagazzal A.M. Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus. Behav. Neurosci. 112:1998;1423-1429.
19. File S.E., Mabbutt P.S., Hitchcott P.K. Characterisation of the phenomenon of 'one-trial tolerance' to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology. 102:1990;98-101.
20. File S.E., Zangrossi H. 'One-trial tolerance' to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology. 110:1993;40-244.
21. File S.E., Zangrossi H. Jr., Sanders F.L., Mabbutt P.S. Raised corticosterone in the rat after exposure to the elevated plus-maze. Psychopharmacology. 113:1994;543-546.
22. File S.E., Zangrossi H. Jr., Viana M., Graeff F.G. Trial 2 in the elevated plus-maze: a different form of fear? Psychopharmacology. 111:1993;491-494.
23. Gonzalez L.E., File S.E. A 5-min experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphé nucleus. J. Neurosci. 17:1997;1505-1511.
24. Gonzalez L.E., Ouagazzal A.M., File S.E. Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphé reveals differential gabaergic control in two animal tests of anxiety. Eur. J. Neurosci. 10:1998;673-3680.
25. Graeff F.G., Silveira M.C.L., Nogueira R.L., Audi E.A., Oliviera R.M.W. Role of the amygdala and periaqueductal gray in anxiety and panic. Behav. Brain Res. 58:1993;123-131.
26. Graeff F.G., Viana M., Tomaz C. The elevated T-maze, a new experimental model of anxiety and memory: effect of diazepam. Braz. J. Med. Biol. Res. 26:1993;104.
27. Gray J.A. Precis of the neuropsychology of anxiety: an inquiry into the functions of the septo-hippocampal system. Behav. Brain Sci. 5:1982;469-534.
28. Holmes A., Rodgers R.J. Responses of swiss-webster mice to repeated plus-maze experience: further evidence for a qualitiative shift in emotional state? Pharmacol. Biochem. Behav. 60:1998;473-488.
29. Irvine E.E., Cheeta S., File S.E. Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav. Pharmacol. 1999;. (In press).
30. 1 receptors. Neuropharmacology. 2000;. (In press).
31. Kenny P.J., File S.E., Neal M.J. Evidence for a dual influence of nicotinic acetylcholine receptors on hippocampal serotonin release. Br. J. Pharmacol. 2000;. (In press).
32. Kenny P.K., Ouagazzal A.-M., File S.E. Bidirectional effects of nicotine on anxiety and the role of the dorsal hippocampus. J. Psychopharmacol. 12(Suppl. A):1998;125.
33. Marks I.M. Fears, Phobias and Rituals. 1987;Oxford Univ. Press, New York, NY.
34. Menard J., Treit D. Lateral and medial septal lesions reduce anxiety in the plus-maze and probe-burying tests. Physiol. Behav. 60:1996;845-953.
35. Ouagazzal A.M., Kenny P.J., File S.E. Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety. Eur. J. Neurosci. 1999;. (in press).
36. Ouagazzal A.M., Kenny P.J., File S.E. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine. Psychopharmacology. 144:1999;54-60.
37. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
38. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24:1986;525-529.
39. Rodgers R.J., Johnson N.J.T. Cholecystokinin and anxiety: promises and pitfalls. Crit. Rev. Neurobiol. 9:1995;345-369.
40. Rodgers R.J., Lee C., Shepherd J.K. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology. 106:1992;102-110.
41. Rodgers R.J., Shepherd J.K. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology. 113:1993;237-242.
42. Shytle R.D., Newman M.B., Amiri L., Wilkinson B., Diamond D.M., Nazian S.J., Silver A.A., Sanberg P.E. Low doses of mecamylamine produce anxiolytic and antidepressant effects in rats. Soc. Neurosci. Abstr. 25:1999;1981.
43. Taukulis H.K., McKay R.W. Postdrug retention of diazepam's effects on habituation to a novel environment in an animal model of anxiety. Behav. Neural Biol. 53:1992;286-293.
44. Treit D., Menard J. Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions. Behav. Neurosci. 111:1997;653-658.
45. Treit D., Menard J. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci. Biohehav. Rev. 23:1999;591-613.
46. Treit D., Menard J., Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav. 44:1993;463-469.
47. Tyrer P. Choice of treatment in anxiety. Tyrer P. Psychopharmacology of anxiety. 1989;254-282 Oxford Medical Publications, Oxford, UK.